Broidrick Amy S. Insider Trades

Insider Trading History

Track insider trading activity for Broidrick Amy S.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Qualigen Therapeutics
Qualigen Therapeutics QLGN
President/cso
Holding Value $417k 130,000 shares
Last Trade
Jul 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.3M 130,000 shares
$240.55
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
President/cso
Holding Value $111k 34,500 shares
Last Trade
Jun 14, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.7M 30,000 shares
$290.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
President/chiefstrategyofficer
Holding Value $963k 300,000 shares
Last Trade
Dec 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$186M 300,000 shares
$620.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Evp, Chief Strategy Officer
Holding Value $14.4k 4,500 shares
Last Trade
Apr 26, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.04M 4,500 shares
$1,120.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Executive Vp, CSO
Holding Value $482k 150,000 shares
Last Trade
Dec 07, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$264M 150,000 shares
$1,760.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Director
Holding Value $161k 50,000 shares
Last Trade
Aug 27, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$118M 50,000 shares
$2,350.00
$3.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up